Aguytrying wrote:Was thinking about this share today. How will the cash injection affect p/l going forward. Ie how much will it reduce interest payment and finance costs. Effect of new shares to pe, NAV.
Anyone with interest please crunch these numbers for us.
CDC new shares - 353,665,200
ESOP- 21,000,000
Existing shares - 495,275,000
Total number of shares now- 869,640,200
PAT in last good year - 1,493,393,000 ( this is what it should get back to when "normal" profitabilty resumes)
EPS - 1.72
PE at (30 )- 17
dilution 43%
Factor in the fact that CDC got in at 40.00. But also remember their gross dividend is high, and maybe benefiting in other ways a minority wouldn't.
Also remember the high PE afforded to safaricom in the same market.
I don't know where its a good price to buy
The investor's chief problem - and even his worst enemy - is likely to be himself